These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20422568)

  • 1. A comparison of laboratory and 'wild' strains of bluetongue virus--is there any difference and does it matter?
    Kirkland PD; Hawkes RA
    Vet Ital; 2004; 40(4):448-55. PubMed ID: 20422568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered structure-based vaccine for bluetongue disease.
    Roy P
    Vet Ital; 2004; 40(4):594-600. PubMed ID: 20422594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion of bluetongue virus in cattle semen: a feature of laboratory-adapted virus.
    Kirkland PD; Melville LF; Hunt NT; Williams CF; Davis RJ
    Vet Ital; 2004; 40(4):497-501. PubMed ID: 20422576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in north-western Europe.
    Mintiens K; Méroc E; Mellor PS; Staubach C; Gerbier G; Elbers AR; Hendrickx G; De Clercq K
    Prev Vet Med; 2008 Oct; 87(1-2):131-44. PubMed ID: 18667252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search for bluetongue viruses in Australia.
    St George TD
    Prog Clin Biol Res; 1985; 178():295-305. PubMed ID: 2989867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of genome segments 2, 7 and 10 of bluetongue viruses serotype 2 for differentiation between field isolates and the vaccine strain.
    Bréard E; Sailleau C; Coupier H; Mure-Ravaud K; Hammoumi S; Gicquel B; Hamblin C; Dubourget P; Zientara S
    Vet Res; 2003; 34(6):777-89. PubMed ID: 14746772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bluetongue vaccines: the past, present and future.
    Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
    Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The history of bluetongue and a current global overview.
    Walton TE
    Vet Ital; 2004; 40(3):31-8. PubMed ID: 20419631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bluetongue viruses, vectors and surveillance in Australia - the current situation and unique features.
    Kirkland PD
    Vet Ital; 2004; 40(3):47-50. PubMed ID: 20419634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the genomes of bluetongue virus serotype 10 vaccines and a recent BTV-10 isolate from Washington.
    Collisson E; Roy P
    Am J Vet Res; 1983 Feb; 44(2):235-7. PubMed ID: 6299144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.
    Batten CA; Maan S; Shaw AE; Maan NS; Mertens PP
    Virus Res; 2008 Oct; 137(1):56-63. PubMed ID: 18598726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae).
    Veronesi E; Hamblin C; Mellor PS
    Vaccine; 2005 Dec; 23(48-49):5509-16. PubMed ID: 16111787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory tests for evaluating the level of attenuation of bluetongue virus.
    Franchi P; Mercante MT; Ronchi GF; Armillotta G; Ulisse S; Molini U; Di Ventura M; Lelli R; Savini G; Pini A
    J Virol Methods; 2008 Nov; 153(2):263-5. PubMed ID: 18706450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of human interventions on the spread of bluetongue virus serotype 8 during the 2006 epidemic in north-western Europe.
    Mintiens K; Méroc E; Faes C; Abrahantes JC; Hendrickx G; Staubach C; Gerbier G; Elbers AR; Aerts M; De Clercq K
    Prev Vet Med; 2008 Oct; 87(1-2):145-61. PubMed ID: 18649960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular differentiation of field and vaccine strains of bluetongue virus serotype 2 using the real-time polymerase chain reaction and fluorescene resonance energy transfer hybridisation probes.
    de Santis P; Orrù G; Solinas F; Piras V; Savini G; Caporale V
    Vet Ital; 2004; 40(4):572-6. PubMed ID: 20422589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological response in cattle and sheep following infection or vaccination with bluetongue virus.
    Savini G; Tittarelli M; Bonfini B; Zaghini M; Di Ventura M; Monaco F
    Vet Ital; 2004; 40(4):645-7. PubMed ID: 20422603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission potential of South African Culicoides species for live-attenuated bluetongue virus.
    Venter GJ; Gerdes GH; Mellor PS; Paweska JT
    Vet Ital; 2004; 40(3):198-202. PubMed ID: 20419662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field vaccination of cattle using a bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production.
    Monaco F; De Luca N; Morelli D; Pisciella M; Palmarini S; Di Giandomenico M; Savini G
    Vet Ital; 2004; 40(4):661-3. PubMed ID: 20422607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A South African overview of the virus, vectors, surveillance and unique features of bluetongue.
    Gerdes GH
    Vet Ital; 2004; 40(3):39-42. PubMed ID: 20419632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.